CytoSorbents Reports Fourth Quarter and Full Year 2021 Results and Provides 2022 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Cytosorbents (CTSO) Misses Q4 EPS by 8c
March 8, 2022 4:18 PM ESTCytosorbents (NASDAQ: CTSO) reported Q4 EPS of ($0.21), $0.08 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $10.8 million versus the consensus estimate of $10.11 million.
For earnings history and earnings-related data on Cytosorbents (CTSO) click here.
... More